Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Microbiology 149 (2003), 2609-2614; DOI  10.1099/mic.0.26142-0
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshida, T.
Right arrow Articles by Yokochi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshida, T.
Right arrow Articles by Yokochi, T.
Agricola
Right arrow Articles by Yoshida, T.
Right arrow Articles by Yokochi, T.
Microbiology 149 (2003), 2609-2614; DOI  10.1099/mic.0.26142-0
© 2003 Society for General Microbiology

Human microvascular endothelial cells resist Shiga toxins by IFN-{gamma} treatment in vitro

Tomoaki Yoshida, Tsuyoshi Sugiyama, Naoki Koide, Isamu Mori and Takashi Yokochi

Department of Microbiology and Immunology, School of Medicine, Aichi Medical University, Yazako, Nagakute, 480-1195 Aichi, Japan

Correspondence
Tomoaki Yoshida
tomo{at}aichi-med-u.ac.jp

Shiga toxins (Stxs) produced by enterohaemorrhagic Escherichia coli or Shigella dysenteriae damage human endothelial cells predominantly in cooperation with pro-inflammatory cytokines, such as TNF-{alpha}. However, in this study, in vitro IFN-{gamma} pre-treatment resulted in human lung microvascular endothelial cells becoming over 10 000-fold less sensitive to Stxs. In contrast, in their basal condition, they were extremely sensitive to Stxs. Interestingly, TNF-{alpha} addition to IFN-{gamma} reverted the Stx-resistant phenotype, which corresponded with its well-established enhancing effect on Stx toxicity. Toxin binding to the cell was barely affected by IFN-{gamma}. Also, the toxin uptake in the Stx-resistant phenotype was more than 100-fold greater than that of normal cells, when compared at Stx concentrations resulting in equivalent degrees of cell damage. Protein synthesis was inhibited by nearly 90 % in the Stx-resistant phenotype after 24 h toxin exposure. This indicated that the intracellular toxin was active as an N-glycosidase, while cells were still over 60 % viable, suggesting a possible unknown cytotoxic function of Stx. In conclusion, this study shows a unique effect of IFN-{gamma} in the suppression of the toxicity of Stxs in a human microvascular endothelial cell model and the involvement of a novel mechanism in this suppression.


Abbreviations: CD50, 50 % cytotoxic dose; HLMEC, human lung microvascular endothelial cell; IFN-{gamma}, {gamma} interferon; Stx, Shiga toxin; TNF-{alpha}, tumour necrosis factor {alpha}







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2003 Society for General Microbiology.